Allele Forms Forms New Clinical Partnerships in Pluripotent Stem Cell Therapy

Allele Biotechnology (founded by SDEE member Jiwu Wang in 2009) formed clinical partnerships with leaders in pluripotent stem cell therapy that are potentially worth tens of millions of dollars. 

Allele Biotech was initially funded with several NIH SBIR grants in the RNA expression and interference field.  More recent funding has come from NIH grants in cancer proteomics, nanobody assays, viral packaging, and stem cells.  As results of the continued research in basic science and applications, the company achieved several patents and publications in high impact areas. 

Allele Biotech just released its newest product line: nano antibodies (nAbs), which are based on camelid antibodies as single domain nanobodies (VHH fragment).  The first group of products include GFP-nAb (replacing the  previous ChromoTek GFP-Trap with higher capacity and superior cleanness), mNeonGreen-nAb, mWasabi-nAb, and His-nAb

Attend SDEE Events Donate | Sponsor SDEE Become a Member

Connect with SDEE

Sign Up for SDEE Newsletter


Morrison Foerster Alexandria


Takeda San Diego BDO logo


Barney and Barney Longfellow Pineapple.gif

SDEE is a nonprofit 501(c)(3) organization founded by local San Diego entrepreneurs
in order to provide a voice for the early stage start-up, to support new entrepreneurs and their companies,
and to sponsor networking and educational events
to help develop the skills necessary to bring funding, business, and jobs to the San Diego area.

© 2015 San Diego Entrepreneurs Exchange. All Rights Reserved